Latest filing published 21 Jul 2025 for Blueprint Medicines Corp. Read the official filing
No signal scores available.
John Tsai appears in our data through filings on Blueprint Medicines Corp shares, published by SEC (Form 4). The record holds 5 filings, for trades running from 6 January 2023 to 17 July 2025.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 21 July 2025 with a transaction in Blueprint Medicines Corp. Typically, a trade is published a median of 3 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations